This competing renewal investigates the involvement of the protein tyrosine phosphatase family of diabetic autoantigens, phogrin (IA-2 beta) and ICA-512 (IA-2) and their invertebrate homologs as targets of T-cells and antibodies in type 1diabetes in the NOD mouse and human subjects. We recently observed that the phogrin molecule incorporates at least two """"""""super-epitopes"""""""" that are presented to autoreactive T-cells in NOD mice and man by multiple class II molecules that confer susceptibility to T1D. To gain insight into the full range of naturally processed epitopes, studies are proposed to map the epitopes recognized by CD4+, and CD8+ T-cells and diabetic autoantibodies to phogrin and IA-2. The project builds upon our previous studies of structural and cell biology of these molecules and investigations of cell-mediated immunity in the NOD mouse. The emphasis here will be to relate these findings to the disease in humans. Thus we will exploit transgenic mouse models in which human MHC class I and II genes have been introduced to define relevant peptide epitopes and altered peptide ligands and proceed from there to studies with human subjects using resources available at the Barbara Davis Center for Childhood Diabetes.
Four specific aims are proposed:
Aim 1. Analysis of the naturally processed peptide epitopes of phogrin and IA-2-that are presented to T-cells in the NOD mouse in the context of MHC class I (H2-Kd, H2-Db) and class II (I-Ag7), and in vivo analysis of unmodified or modified versions of these peptides as tolerogens.
Aim 2. Analysis of the naturally processed peptide epitopes of phogrin and IA-2-that are presented to T-cells in transgenic mice that carry HLA transgenes that are associated with type 1 diabetes in man namely HLA-DQ8 (DQA 1 *0301, DQB 1*0302), -DR3 (DRB 1*0301), -DR4 (DRB 1*0401 ), and -A2 (A*0201).
Aim 3. Evaluation of spontaneous T-cell responses to such epitopes in prediabetic and new onset type 1 diabetic human subjects.
Aim 4. Structural mapping of autoantibody binding sites in the IA-2 and phogrin molecules, and analysis of the influence of these autoantibodies on processing and presentation of the intact antigens. The definition of potential """"""""super-epitopes"""""""" in IA-2 and phogrin has important implications for antigen-based therapies. The ability to present an autoantigenic peptide simultaneously on multiple HLA molecules overcomes one of theoretical limitation to the use of altered peptide ligands as tolerogens as it reduces the numbers and combinations that may be required to restore tolerance. Further understanding of B-cell epitopes at the structural level will likely improve the predictive power of this key diagnostic tool, and might identify potentially suppressive epitopes that could be targeted therapeutically.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IMM-A (01))
Program Officer
Spain, Lisa M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Schools of Medicine
United States
Zip Code
Kozhakhmetova, A; Wyatt, R C; Caygill, C et al. (2018) A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. Clin Exp Immunol 192:251-258
Culina, Slobodan; Lalanne, Ana Ines; Afonso, Georgia et al. (2018) Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol 3:
Lahner, Edith; Brigatti, Cristina; Marzinotto, Ilaria et al. (2017) Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients. Clin Transl Gastroenterol 8:e215
Vendrame, F; Hopfner, Y-Y; Diamantopoulos, S et al. (2016) Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants. Am J Transplant 16:235-45
Burke 3rd, George W; Chen, Linda J; Ciancio, Gaetano et al. (2016) Biomarkers in pancreas transplant. Curr Opin Organ Transplant 21:412-8
Burke 3rd, George W; Vendrame, Francesco; Virdi, Sahil K et al. (2015) Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity. Curr Diab Rep 15:121
Demeester, Simke; Keymeulen, Bart; Kaufman, Leonard et al. (2015) Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual ?-cell function in recent-onset type 1 diabetes. Diabetes Care 38:644-51
Wang, Bin; Hawa, Mohammed I; Rijsdijk, Frühling V et al. (2015) Heritability of thyroid peroxidase autoantibody levels in type 1 diabetes: evidence from discordant twin pairs. Diabetologia 58:2079-86
Asanghanwa, Milca; Gorus, Frans K; Weets, Ilse et al. (2014) Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients. Diabetes Res Clin Pract 103:97-105
Davidson, Howard W; Wenzlau, Janet M; O'Brien, Richard M (2014) Zinc transporter 8 (ZnT8) and ? cell function. Trends Endocrinol Metab 25:415-24

Showing the most recent 10 out of 40 publications